Global Orthokeratology Lens Market: Information by Material (Silicone Acrylate, Fluorosilicone Acrylate and Fluorocarbon Acrylate), Application (Myopia and Hyperopia), End User (Hospitals and Ophthalmic Clinic) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

Market Overview

Global Orthokeratology Lens Market is expected to register a CAGR of 7.4% to reach USD 3,857.8 Million till 2025.

Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. It is a non-surgical method used to correct refractive errors by reshaping the curvature of the cornea to improve object visibility. This procedure is a temporary treatment method used for the correction of myopia, hypermetropia, and other eye-related problems.

The growing prevalence of refractive errors across the globe, advancements in the field of ophthalmology over the past couple of decades and low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is expected to enhance the market growth. However, the availability of alternative treatment methods and risk associated with orthokeratology are projected to curb the growth of the market.

Market Dynamics

A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods. Myopia is reported as the most common disorder affecting a large number of populations worldwide. The World Health Organization 2018 fact sheet estimated that approximately 1.3 billion people were living with some form of vision impairment. It also reported that 188.5 million patients have a mild vision impairment, 217 million people have moderate to severe vision impairment, and 36 million people are blind, globally. Such a vast population suffering from eye problems boosts market growth during the forecast period.

Global Orthokeratology Lens Market Share, by Application, 2018 & 2025 (USD MILLION)  

Source: MRFR Analysis

Segmentation

The global orthokeratology lens market, by material, has been segmented into silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. On the basis of application, the global orthokeratology lens market has been segmented into myopia and hyperopia. Based on end user, the market has been segmented into hospitals and ophthalmic clinic.

Regional Analysis

The global orthokeratology lens market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global orthokeratology lens market. The growth of the Americas can be attributed to its rising geriatric population and increasing ophthalmological disorders, causing an increased need for diagnosis and therapeutics.

Asia-Pacific is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are the rising patient population of people with eye disorders, availability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the presence of good healthcare infrastructure. According to the Asian Development Bank, the elderly population in Asia is projected to reach nearly 923 million by 2050.

Europe is estimated to be growing at the fastest pace in the global market due to the increasing cases of eye disorders and increasing government initiatives are driving the growth of the market. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired.

The orthokeratology lens market in the Middle East & Africa is expected to exhibit the least growth in the global orthokeratology lens market due to factors such as limited access to healthcare affordability issues.  

Key Players

The prominent players in the global orthokeratology lens market are Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Procornea (CooperVision) (Eerbeek, Netherlands), Euclid Systems Corporation (Virginia), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas) and CONTAMAC (Essex).

Some of the key strategies followed by players operating in the global orthokeratology lens market were innovation, product development, and acquisition & mergers.

• In February 2019, Contamac introduced HyClear, the next generation hypochlorous acid 0.01% solution for daily eyelid health management. It is manufactured utilizing a new proprietary manufacturing process that provides a pure, stable, and effective solution for daily dry eye management.

• In March 2019, Alcon, Inc. announced that it had acquired PowerVision, Inc., a US-based medical device development company focused on creating fluid-based intraocular lens implants.

• In December 2016, CooperVision acquired Soflex, a contact lens manufacturer, to grow their eye care portfolio.

Market Segmentation

Global Orthokeratology Lens Market, by Material

• Silicone Acrylate


• Fluorosilicone Acrylate


• Fluorocarbon Acrylate

Global Orthokeratology Lens Market, by Application

• Myopia


• Hyperopia

Global Orthokeratology Lens Market, by End User

• Hospitals


• Ophthalmic Clinic

Global Orthokeratology Lens Market, by Region

• Americas
  
  
  
  • North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • Latin America
  
  
  
  

• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • UK
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  

• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  

• Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Available Additional Customizations

• Company Profiles of Other Key Players
  
  
  
  • Autek
  
  
  • Paragon
  
  
  • Alpha Corporation
  
  
  • Lucid Korea
  
  
  
  


• Orthokeratology Lens Market, Industry Trends

Intended Audience

• Medical device companies


• Contract research manufacturing organizations


• Research & development organizations


• Academic institutes

Report Scope:

Report Attribute/Metric	Details
Market Size	2025: 3,857.8 Million 2027: Significant value
CAGR	7.4% (2018-2025)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Material, Application, End User and Region
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Procornea (CooperVision) (Eerbeek, Netherlands), Euclid Systems Corporation (Virginia), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas) and CONTAMAC (Essex).
Key Market Opportunities	The growing prevalence of refractive errors across the globe. Advancements in the field of ophthalmology over the past couple of decades. Low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment
Key Market Drivers	A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods.

Frequently Asked Questions (FAQ) :

---